BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
Vote for Target Test Prep, Newsweek Readers’ Choice Awards 2026
NEWSWEEK READERS’ CHOICE 2026

BIG NEWS! Target Test Prep has been nominated, and they’d love your vote!

TTP has worked incredibly hard to build the best test prep experience possible, and winning Newsweek’s 2026 Readers’ Choice Award for Best Test Prep would mean a lot to them. If TTP has helped you, they’d be incredibly grateful for your vote. You can vote once each day through September 9.

Vote for TTP
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

Pharmaceutical companies spend more than ever on research an

Expert replies
by BTGmoderatorDC » Sat Oct 05, 2019 4:13 pm
Pharmaceutical companies spend more than ever on research and development; yet the number of new drugs patented each year has dropped since 1963. At the same time, profits-at constant 1963 dollars-for the industry as a whole have been steadily increasing.

Which of the following, if true, is the single factor most likely to explain, at least in part, the three trends mentioned above for money spent, drugs patented, and profits made?

A. Government regulations concerning testing requirements for novel drugs have become steadily more stringent.

B. Research competition among pharmaceutical companies has steadily intensified as a result of a general narrowing of research targets to drugs for which there is a large market.

C. Many pharmaceutical companies have entered into collaborative projects with leading universities, while others have hired faculty members away from universities by offering very generous salaries.

D. The number of cases in which one company's researchers duplicated work done by another company's researchers has steadily grown.

E. The advertising budgets of the major pharmaceutical companies have grown at a higher rate than their profits have.

OA B

Source: Official Guide
Join the discussion
Source: — Critical Reasoning |

by deloitte247 » Sun Oct 13, 2019 2:24 pm
Conclusion: Pharmaceutical companies spend more than ever on research and development. However, the number of new drugs patented each year dropped since 1963 as well as the profits at constant 1963 dollars have been increasing steadily.

Option A - Incorrect
Government intervention concerning testing requirement for nove; drugs is not in harmony with the argument. Hence, we are not concerned about this claim.

Option B - Correct
This explains the argument because the pharmaceutical companies spend more than ever on research and development. Nevetheless, there has been a drop in new drugs patented since 1963, while the profits has been increasing alongside.

Option C - Incorrect
We can't know from the passage if pharmaceutical companies collaborated with leading universities or hire faculty members. This claim is unfounded.

Option D - Incorrect
This is not relevant to the argument because no record of duplication was stated in the passage.

Option E - Incorrect
There is no concrete evidence to back this up. No information was given about the rate of advertising budget of pharmaceutical companies.
Join the discussion